Kopetz Kopetz S S Desai Desai J J Chan Chan E E Phase II pilot study of vemurafenib in patients with metastatic BRAF-mutated colorectal cancer Phase II pilot study of vemurafenib in patients with metastatic BRAF-mutated colorectal cancer J Clin Oncol J Clin Oncol 2015 2015 33 33 4032 4032 4038 4038 10.1200/JCO.2015.63.2497 10.1200/JCO.2015.63.2497 supplied-pmid 4669589? Here, BRAF is linked to colorectal cancer.